R. Mollife

Anti-tumor activity of abiraterone acetate (AA), a CYP17 inhibitor of androgen synthesis, in chemotherapy naive and docetaxel pre-treated castration resistant prostate cancer (CRPC)

M. Dowsett, D. Dearnaley, C. Parker, 2008 .